Shaun Sebastian Sim

6PUBLICATIONS
6CO-AUTHORS
Major global burdens of diseaseOphthalmology and optometry not elsewhere classifiedOptical technologyCancer therapy (excl. chemotherapy and radiation therapy)Peripheral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 10, 2023
The economic burden of inherited retinal disease in Singapore: a prevalence-based cost-of-illness study.

Junxing Chay, Rachael Wei Chao Tang, Tien-En Tan

|Jan 20, 2022
Infographic: non-ICGA imaging for polypoidal choroidal vasculopathy (PCV) - Asia-Pacific Ocular Imaging Society PCV workgroup report 1 & 2.

Christopher Ziyu Sun, Shaun Sebastian Khung Peng Sim, Chinmayi Himanshuroy Vyas

|Jan 10, 2022
Infographic: "Planet Trial: Intravitreal aflibercept monotherapy for polypoidal choroidal vasculopathy (PCV)".

Shaun Sebastian Sim, Chinmayi Himanshuroy Vyas, Rubamalar Gunatheesan

|Jan 09, 2022
Infographic: Everest II study "Which is superior? Combination therapy or monotherapy for polypoidal choroidal vasculopathy (PCV) treatment".

Chinmayi Himanshuroy Vyas, Pooi Wah Lott, Rubamalar Gunatheesan

|Jul 15, 2021
Evolving treatment paradigms for PCV.

Beau J Fenner, Chui Ming Gemmy Cheung, Shaun S Sim

|Oct 29, 2020
Anti-retinal autoantibodies in myopic macular degeneration: a pilot study.

Shaun Sebastian Sim, Chee Wai Wong, Quan V Hoang

Pageof 1